In eyes with primary open-angle glaucoma, identifying where blockage or resistance occurs within the conventional outflow pathway can be hard.
Targeting the trabecular meshwork alone, or isolating a single point, may not be enough to lower IOP.
- 75% of Surgeons want to address the conventional outflow pathway first
- Between 50-75% of resistance may be in the Trabecular Meshwork
- Up to 50% of resistance may be in Schlemm’s canal and the distal collector channels
OMNI® targets all three points of resistance.
- Trabecular meshwork
- Schlemm’s canal
- Collector channels
ONE MIGS device
TWO implant-free procedures
THREE points of resistance
Meet the next generation OMNI® Surgical System.
With the OMNI® Surgical System, you can perform two implant-free procedures targeting three points of resistance with one intelligent device.
Two procedures in one
intelligently designed device.
The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.
With its unique implant-free approach, the OMNI® Surgical System lets you access Schlemm’s canal with the microcatheter through a single clear corneal incision. Intelligently engineered with an internal reservoir delivering a controlled amount of viscoelastic fluid.
To address the trabecular meshwork as a point of resistance within the conventional outflow pathway, the OMNI® Surgical System lets you perform a titratable trabeculotomy customized to meet your surgical plan.